[1] 孙燕.内科肿瘤学[M].北京:人民卫生出版社,2001.497-501. [2] Harbaugh KS, Black PM. Strategies in the surgical management of malignant gliomas[J]. Semin Surg Oncol, 1998, 14(1): 26-33. [3] Gaspar LE, Zamorano LJ, Shamsa F, et al. Permanent 125iodine implants for recurrent malignant gliomas [J]. Radiat Oncol Biol Phys, 1999, 43(5): 977-82. [4] Halligan JB, Stelzer KJ, Rostomily RC, et al. Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas[J]. Int J Radiat Oncol Biol Phys, 1996, 35(3): 541-7. [5] Crossen JR, Garwood D, Glatstein E. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy[J]. Clin Oncol, 1994, 12: 627-42. [6] Burton EC, Prados MD. Malignant gliomas[J]. Curr Treat Options Oncol, 2000, 1(5): 459-68. [7] Nieder C, Grosu AL, Molls M, et al. A comparison of treatment results for recurrent malignant gliomas [J]. Cancer Treat Rev, 2000,26(6): 397-409. [8] Eljamel MS. New light on the brain: The role ofphotosensitizing agents and laser light in the management of invasive intracranial tumors[J]. Technol Cancer Res Treat, 2003, 2(4): 303-9. [9] Gupta S, Dwarakanath BS, Muralidhar K, et al. Role of apoptosis in photodynamic sensitivity of human tumour cell lines [J]. Exp Biol,2003, 41(1): 33-40. [10] Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors[J]. Clin Laser Med Surg, 1996, 14(5): 251-61. [11] Goetz C, Hasan A, Stummer W. Experimental research photodynamic effects in perifocal, oedematous brain tissue[J]. Acta Neurochir (Wien), 2002, 144(2): 173-9. [12] Muller PJ, Wilson BC. Photodynamic therapy for recurrent supratentorial glinmas[J]. Semin Surg Oncol, 1995, 11(5): 346-54. [13] Mason JO, Fischer DH. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma [J]. Ophthalmology, 2003,110(6): 1241-4. |